Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
SAB Biotherapeutics
Biotech
A 'live fire exercise' with COVID preps SAB for new (old) focus
SAB signed a small contract with the DOD in September 2019 to develop an antibody for “an unknown threat.” Little did they know what they were in for.
Annalee Armstrong
Oct 16, 2023 6:00am
SAB's COVID-19 drug tries to find footing in omicron era
Apr 26, 2023 2:42pm
SAB vows to plow ahead with COVID-19 therapy after NIH drops out
Apr 1, 2022 10:35am
Synairgen ACTIV-2 trial paused while NIH tweaks study design
Mar 3, 2022 3:30pm
SAB Biotherapeutics banks $60M more for COVID-19 antibody
Sep 22, 2021 3:35pm